According to research report " Urinalysis Market
by Product Type (Dipstick, Reagent, Analyzers, POC), Test Type
(Biochemical, Sediment, Microscopic, Flow-Cytometric), Application
(Diabetes, UTI, Kidney, Liver Disease, Pregnancy), End User (Hospitals,
Diagnostic Labs) - Forecast to 2021",
Report provides a detailed overview of the major drivers, restraints,
challenges, opportunities, current market trends, and strategies
impacting the urinalysis market along with the estimates and forecasts
of the revenue and market share analysis.
The global Urinalysis market
is expected to reach USD 1.91 Billion by 2021 from USD 1.32 Billion in
2016 at a CAGR of 7.6% from 2016 to 2021. The major factors driving the
growth of this market are rising prevalence of kidney diseases and
urinary tract infections, implementation of PPACA, technological
advancements, increasing adoption rate of point-of-care urinalysis
devices, increasing healthcare expenditure and increasing geriatric
population.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294
The reporting segments in
this market include product type, test type, applications, and end user.
On the basis of product type, the urinalysis market is segmented into
consumables and instruments. Consumables are expected to account for the
largest share of the market due to factors such as wide use of
disposables in urinalysis testing and research, the introduction of new
and advanced reagents & dipsticks and the utilization of disposables
at a larger scale in the market.
On the basis of test type,
the urinalysis market is segmented into biochemical urinalysis and
sediment urinalysis. The biochemical urinalysis segment is expected to
account for the largest share of the global urinalysis market in 2016.
The rapidly growing geriatric population and rising prevalence of kidney
diseases and urinary tract infections are the key factors propelling
the growth of this market.
On the basis of end user, the
urinalysis market includes hospitals and clinical laboratories,
diagnostics laboratory, research laboratories and institutes and home
care settings. The hospitals and clinical laboratories segment is
expected to account for the largest share of the global urinalysis
market in 2016. Extensive use of dipsticks by hospitals and clinical
laboratories is the major factors driving the growth of this market.
Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294
Based on applications, the
global urinalysis market is segmented into disease diagnostics and
pregnancy tests. Disease diagnostics segment is expected to account for
the largest share of the market during the forecast period. Growth in
this segment is driven by the factors such as advancement in the
development of new urinalysis tests for better and early diagnosis of
chronic diseases.
Based on geography, the
global urinalysis market is segmented into North America, Europe, Asia
and Row. Asia segment is expected to grow at the highest CAGR during the
forecast period. Growth in this segment is driven by the factors such
as rising demand for urine testing products, increasing healthcare
expenditure, rising prevalence of diabetes, and growing geriatric
population are driving the growth of the urinalysis market in this
region.
The key players in the
urinalysis market include Beckman Coulter (U.S.), Roche Diagnostics
(Switzerland), Siemens AG (Germany), Sysmex Corporation (Japan) and
ARKRAY, Inc. (Japan).
No comments:
Post a Comment